Abstract
In the fall of 2014, the leaders of the high-profile nonprofit program Stand Up To Cancer (“SU2C”), whose mission is to raise awareness and funds to increase the pace of groundbreaking translational research that can get new therapies to patients quickly, and a group at the Institute for Advanced Study in Princeton, New Jersey, a world-famous center for theoretical research in physics and mathematics, teamed up to propose a multidisciplinary meeting to explore novel approaches to cancer research. The participants would include quantitative scientists from various areas of the physical sciences (theoretical physicists, mathematicians, computer scientists, and engineers) and clinical oncologists, two groups whose disparate research fields do not traditionally intersect. They would be invited to a multiday meeting in order to develop research projects integrating quantitative approaches and clinical cancer research—an exercise in convergence science. The success of the meeting that eventually resulted from this partnership, in engaging a very diverse group of researchers in developing creative, quantitative science-based approaches to advance cancer research using clinical data, ultimately led to the formation of four cross-institutional, multidisciplinary teams of researchers pursuing novel translational research projects that are being funded through a combination of private–public grants. The collaborative efforts that resulted in the February 2015 Convergence Ideas Lab meeting and these Convergence Teams are described below, and might provide guidance for others seeking to organize and facilitate cross-disciplinary interactions to stimulate innovation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alexandrov LB, Nik-Zainal S, Wedge DC, Campbell PJ, Stratton MR. Deciphering signatures of mutational processes operative in human cancer. Cell Rep. 2013;3(1):246–59. https://doi.org/10.1016/j.celrep.2012.12.008.
Balachandran VP, Łuksza M, et al. Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer. Nature. 2017;551:512–6.
Guryanova OA, Shank K, Spitzer B, Luciani L, Koche RP, Garrett-Bakelman FE, Ganzel C, Durham BH, Mohanty A, Hoermann G, Rivera SA, Chramiec AG, Pronier E, Bastian L, Keller MD, Tovbin D, Loizou E, Weinstein AR, Gonzalez AR, Lieu YK, Rowe JM, Pastore F, McKenney AS, Krivtsov AV, Sperr WR, Cross JR, Mason CE, Tallman MS, Arcila ME, Abdel-Wahab O, Armstrong SA, Kubicek S, Staber PB, Gönen M, Paietta EM, Melnick AM, Nimer SD, Mukherjee S, Levine RL. DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling. Nat Med. 2016;22(12):1488–95. https://doi.org/10.1038/nm.4210.
Hata AN, Niederst MJ, Archibald HL, et al. Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition. Nat Med. 2016;22(3):262–9. https://doi.org/10.1038/nm.4040.
Le X, Antony R, Razavi P, Treacy DJ, Luo F, Ghandi M, Castel P, Scaltriti M, Baselga J, Garraway LA. Systematic functional characterization of resistance to PI3K inhibition in breast cancer. Cancer Discov. 2016;6(10):1134–47.
Łuksza M, Riaz N, Makarov V, Balachandran VP, Hellmann MD, Solovyov A, Rizvi NA, Merghoub T, Levine AJ, Chan TA, Wolchok JD, Greenbaum BD. A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy. Nature. 2017;551:517–20.
Ni X, Zhuo M, Su Z, et al. Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients. Proc Natl Acad Sci. 2013;110(52):21083–8. https://doi.org/10.1073/pnas.1320659110.
NRC (National Research Council). Convergence: facilitating transdisciplinary integration of life sciences, physical sciences, engineering, and beyond. Washington, DC: The National Academies Press; 2014.
Tanne A, Muniz LR, Puzio-Kuter A, Leonova KI, Gudkov AV, Ting DT, Monasson R, Cocco S, Levine AJ, Bhardwaj N, Greenbaum BD. Distinguishing the immunostimulatory properties of noncoding RNAs expressed in cancer cells. PNAS. 2015;112(49):15154–9. https://doi.org/10.1073/pnas.1517584112.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Christen, S.P., Levine, A.J. (2019). Facilitating Cross-Disciplinary Interactions to Stimulate Innovation: Stand Up to Cancer’s Matchmaking Convergence Ideas Lab. In: Hall, K., Vogel, A., Croyle, R. (eds) Strategies for Team Science Success. Springer, Cham. https://doi.org/10.1007/978-3-030-20992-6_19
Download citation
DOI: https://doi.org/10.1007/978-3-030-20992-6_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-20990-2
Online ISBN: 978-3-030-20992-6
eBook Packages: Behavioral Science and PsychologyBehavioral Science and Psychology (R0)